plerixafor

Spain

Drugs containing this active substance

  • MOZOBIL 20 MG/ML SOLUTION FOR INJECTION

    It is used to help collect stem cells from the blood of adult patients with lymphoma or multiple myeloma, and children aged 1 to less than 18 years with lymphoma or solid tumors, so that they can be stored and used in a transplant.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg

    ATC: L03A L03AX L03AX16

    Manufacturer: Sanofi B.V.

  • It is used to help collect stem cells from the blood of patients who require a transplant. It helps release these cells from the bone marrow into the bloodstream so they can be collected, stored, and then reintroduced into the patient.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg

    ATC: L03A L03AX L03AX16

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to help collect stem cells from the blood of patients who need a transplant. It is prescribed in adults with lymphoma or multiple myeloma, and in children aged 1 to less than 18 years with lymphoma or solid tumors, when the mobilization of these cells is poor.

    Form: solution for injection

    Active substance Dosage
    plerixafor 24 mg

    ATC: L03A L03AX L03AX16

    Manufacturer: Eugia Pharma (Malta) Limited

  • It is used to help release stem cells from the bone marrow into the bloodstream so they can be collected, stored, and used later in a transplant. It is prescribed in adults with lymphoma or multiple myeloma, and in children aged 1 to less than 18 years with lymphoma or solid tumors.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg

    ATC: L03A L03AX L03AX16

    Manufacturer: Glenmark Arzneimittel Gmbh

  • It is used to help release stem cells from the bone marrow into the bloodstream so they can be collected, stored, and used later in a transplant. It is prescribed in adults with lymphoma or multiple myeloma, and in children aged 1 to less than 18 years with lymphoma or solid tumors.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg/ml

    ATC: L03A L03AX L03AX16

    Manufacturer: Seacross Pharma (Europe) Limited

  • It is used to help collect stem cells from the blood of adult patients with lymphoma or multiple myeloma, and children between 1 and under 18 years old with lymphoma or solid tumors. This allows these cells to be collected, frozen, and stored for a future transplant.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg/ml

    ATC: L03A L03AX L03AX16

    Manufacturer: Tarbis Farma S.L.